The impact of sarcopenia on patients undergoing treatment for pancreatic ductal adenocarcinoma

The impact of sarcopenia on patients undergoing treatment for pancreatic ductal adenocarcinoma

Abstract. Introduction:. Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer that disproportionately affects geriatric patients. Combination therapy with surge. ry and chemotherapy is associated with longer survival than medical treatment or supportive care. Preoperative selection of patients...

Full description

Bibliographic Details
Main Authors: Julia R. Amundson, MD, MPH, Jelani K. Williams, MD, Andrew J. Benjamin, MD, MS, Hunter D.D. Witmer, MD, Kevin K. Roggin, MD
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2020-06-01
Series:Journal of Pancreatology
Online Access:http://journals.lww.com/10.1097/JP9.0000000000000046

Internet

http://journals.lww.com/10.1097/JP9.0000000000000046

Similar Items